77 related articles for article (PubMed ID: 32196814)
1. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
[TBL] [Abstract][Full Text] [Related]
2. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia.
Sarkar S; Rav E; Stitzlein L; Gibson A; McCall D; Nunez C; Roth M; Ragoonanan D; Connors J; Herzog CE; Cuglievan B; Garcia MB
Pediatr Blood Cancer; 2024 Jun; 71(6):e30964. PubMed ID: 38514796
[No Abstract] [Full Text] [Related]
3. A rare KMT2A::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome.
Yu J; Song F; Zhang M; Xiao P; Feng J; Hong R; Hu Y; Huang H; Wei G
Mol Biol Rep; 2024 Apr; 51(1):561. PubMed ID: 38643442
[TBL] [Abstract][Full Text] [Related]
4. Raman spectroscopy can recognize the KMT2A rearrangement as a distinct subtype of leukemia.
Leszczenko P; Nowakowska AM; Jakubowska J; Pastorczak A; Zabczynska M; Mlynarski W; Baranska M; Ostrowska K; Majzner K
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 314():124173. PubMed ID: 38520957
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic obesity syndrome: rare presentation of CNS+ B-cell lymphoblastic lymphoma.
Quigg TC; Haddad NG; Buchsbaum JC; Shih CS
Pediatr Blood Cancer; 2012 Nov; 59(5):930-3. PubMed ID: 22213612
[TBL] [Abstract][Full Text] [Related]
6. [Acute lymphoblastic leukemia with inv(11)(q21q23.3)/KMT2A::MAML2 fusion gene progressed to acute myeloid leukemia: a case report].
Zhang Y; Ni JB; Zhang QJ; Hui S; Wang CF; Wang T
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):196. PubMed ID: 38604799
[No Abstract] [Full Text] [Related]
7. B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy.
Carulli G; Marini A; Ferreri MI; Azzarà A; Ottaviano V; Lari T; Rocco M; Giuntini S; Petrini M
Hematol Rep; 2012 Jul; 4(3):e15. PubMed ID: 23087804
[TBL] [Abstract][Full Text] [Related]
8. Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.
Cheung LC; Aya-Bonilla C; Cruickshank MN; Chiu SK; Kuek V; Anderson D; Chua GA; Singh S; Oommen J; Ferrari E; Hughes AM; Ford J; Kunold E; Hesselman MC; Post F; Faulk KE; Breese EH; Guest EM; Brown PA; Loh ML; Lock RB; Kees UR; Jafari R; Malinge S; Kotecha RS
Leukemia; 2023 Jan; 37(1):61-71. PubMed ID: 36380143
[TBL] [Abstract][Full Text] [Related]
9. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
[TBL] [Abstract][Full Text] [Related]
10. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
Kulczycka M; Derlatka K; Tasior J; Sygacz M; Lejman M; Zawitkowska J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612531
[TBL] [Abstract][Full Text] [Related]
11. NG2 Molecule Expression in Acute Lymphoblastic Leukemia B Cells: A Flow-Cytometric Marker for the Rapid Identification of
Bisegna ML; Peragine N; Elia L; Matarazzo M; Milani ML; Intoppa S; Di Trani M; Malfona F; Martelli M; De Propris MS
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024018. PubMed ID: 38468826
[TBL] [Abstract][Full Text] [Related]
12. The discovery of potent USP2/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364.
Tian Y; Liu K; Wu D; Wu L; Xu Q; Wei W; Li Z; Du Q; Bian J
Eur J Med Chem; 2024 Mar; 268():116275. PubMed ID: 38452725
[TBL] [Abstract][Full Text] [Related]
13. Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.
van Weelderen RE; Harrison CJ; Klein K; Jiang Y; Abrahamsson J; Alonzo T; Aplenc R; Arad-Cohen N; Bart-Delabesse E; Buldini B; De Moerloose B; Dworzak MN; Elitzur S; Fernández Navarro JM; Gamis AS; Gerbing RB; Goemans BF; de Groot-Kruseman HA; Guest EM; Ha SY; Hasle H; Kelaidi C; Lapillonne H; Leverger G; Locatelli F; Miyamura T; Noren-Nystrom U; Polychronopoulou S; Rasche M; Rubnitz JE; Stary J; Tierens A; Tomizawa D; Zwaan MC; Kaspers GJL
Blood Adv; 2024 Apr; ():. PubMed ID: 38621200
[TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Faulk KE; Kairalla JA; Dreyer ZE; Carroll AJ; Heerema NA; Devidas M; Carroll WL; Raetz EA; Loh ML; Hunger SP; Borowitz M; Wang C; Guest E; Brown PA
Pediatr Blood Cancer; 2023 May; ():e30467. PubMed ID: 37259259
[TBL] [Abstract][Full Text] [Related]
15. Fusion of Platelet Derived Growth Factor Receptor Alpha (
Panagopoulos I; Andersen K; Gorunova L; Lobmaier I
Cancer Genomics Proteomics; 2024; 21(3):252-259. PubMed ID: 38670591
[TBL] [Abstract][Full Text] [Related]
16. Fusion transcripts are present in early progenitor cells in KMT2A-rearranged B-ALL.
Tirtakusuma R; Milne P; Blair HJ; Shi Y; Bomken S; Heidenreich O
Leukemia; 2024 Apr; 38(4):883-886. PubMed ID: 38307942
[No Abstract] [Full Text] [Related]
17. Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study.
Renaud J; Goemans BF; Locatelli F; Pigazzi M; Redmond S; Kuehni CE; Destaillats A; Alonzo TA; Gerbing RB; Gamis A; Aplenc R; Renella R; Cooper T; Ceppi F
Pediatr Blood Cancer; 2024 Apr; ():e31006. PubMed ID: 38616361
[TBL] [Abstract][Full Text] [Related]
18. KMT2A-rearranged B-lymphoblastic leukemia/lymphoma with surface light chain restriction and lacking immature markers.
Fu L; Gong S
Blood; 2023 Dec; 142(25):2220. PubMed ID: 38127411
[No Abstract] [Full Text] [Related]
19. A pediatric case of
Murphy L; Siegele B; Carstens B; Hartman L; Faulk K
Leuk Lymphoma; 2024 Feb; ():1-5. PubMed ID: 38372299
[No Abstract] [Full Text] [Related]
20. Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.
Burmeister T; Ströh AS; Kehden B; Trautmann H; Meyer C; Marschalek R; Larghero P; Schwartz S; Steffen B; Spriewald B; Heinicke T; Jäkel N; Westermann J; Nachtkamp K; Viardot A; Topp MS; Neumann M; Baldus CD; Gökbuget N; Brüggemann M
Leukemia; 2024 Mar; ():. PubMed ID: 38519799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
